Live Symposium
Cell and gene therapies are creating new possibilities for treating cancer, rare diseases, and genetic disorders. As the field advances, researchers are working to improve therapeutic specificity and safety while developing more effective approaches for clinical translation and scalable manufacturing.
In this two-day symposium, experts from academia and industry will share advances across the cell and gene therapy pipeline, from gene and cell engineering to safety assessment and process development.
Topics to be covered:
- Gene therapy approaches for rare and common diseases
- On- and off-target screening in CAR-T development
- Advances in cell engineering, genome editing, and gene delivery
- Process development and scalable manufacturing
- Translating cell and gene therapies toward the clinic
Tuesday November 17th - Wednesday November 18th, 2026
11:00 AM - 3:00 PM ET
This symposium will be available to view live and on demand.
Speakers
Stephanie Cherqui, PhD
Professor
University of California San Diego
Brandon Cieniewicz
Director
CERo Therapeutics
Le Cong, PhD
Associate Professor
Stanford University
Nicholas Clarkson
Vice President and Head of Process Development
Oxford Biomedica
Dominique Badea, PhD
Lead Scientific Application Specialist
PHC Corporation of North America
Tia Harmon, PhD
Technical Science Liaison
PHC Corporation of North America
Steven A. Goldman, MD, PhD
URMC Distinguished Professor
Rochester's Center for Translational Neuromedicine
Samir Afif, PhD
Senior Account Manager
Countable Labs
Romain Le Bail, PhD
Business Development Manager, Spatial Biology
Bio-Techne
Pier-Anne LaChance, PhD
Senior Director of Quality Control & Product Development
Genprex, Inc
Jun Li, PhD
Head of Preclinical Oncology
GemPharmatech
Executive Sponsor
.png)
Technology Spotlight
.png)
Standard Sponsors
.png)
.png)